These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33285035)

  • 1. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
    Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
    Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data.
    Rosenberg CA; Rodrigues MA; Bill M; Ludvigsen M
    Sci Rep; 2024 Apr; 14(1):9349. PubMed ID: 38654058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
    Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
    Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
    Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
    Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro.
    Han SY; Lee EM; Kim S; Kwon AM; Baek EJ
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome.
    Dong XM; Zhao K; Zheng WW; Xu CW; Zhang MJ; Yin RH; Gao R; Tang LJ; Liu JF; Chen H; Zhan YQ; Yu M; Ge CH; Gao HY; Li X; Luo T; Ning HM; Yang XM; Li CY
    FASEB J; 2020 Jun; 34(6):8416-8427. PubMed ID: 32350948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
    Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
    Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
    Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
    Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyserythropoiesis of myelodysplastic syndromes.
    Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
    Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the implications of erythroblasts periodic acid-Schiff stain in myelodysplastic syndromes].
    Liu L; Cui W; Zhang HL; Xu ZF; Zhang FK; Zheng YZ; Zhang Y; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):259-64. PubMed ID: 21569710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
    Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
    Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
    Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
    Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.
    Aoyama K; Shinoda D; Suzuki E; Nakajima-Takagi Y; Oshima M; Koide S; Rizq O; Si S; Tara S; Sashida G; Iwama A
    Leukemia; 2021 Apr; 35(4):1156-1165. PubMed ID: 32820269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD43 and CD49d from the B-Cell Chronic Lymphoproliferative Disorders Diagnostic Panel Are Useful to Detect Erythroid Dysplasia.
    Oliveira M; Laranjeira P; Fortuna M; Bártolo R; Ribeiro A; Santos M; Cortesão E; Marques G; Sarmento-Ribeiro AB; Vitória H; Ribeiro L; Paiva A
    Cytometry B Clin Cytom; 2019 Sep; 96(5):417-425. PubMed ID: 31157955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
    Shameli A; Dharmani-Khan P; Luider J; Auer I; Shabani-Rad MT
    Cytometry B Clin Cytom; 2021 Sep; 100(5):574-589. PubMed ID: 33369070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
    Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
    Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
    Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
    Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.
    Herbig M; Jacobi A; Wobus M; Weidner H; Mies A; Kräter M; Otto O; Thiede C; Weickert MT; Götze KS; Rauner M; Hofbauer LC; Bornhäuser M; Guck J; Ader M; Platzbecker U; Balaian E
    Sci Rep; 2022 Jan; 12(1):870. PubMed ID: 35042906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
    Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.